130 related articles for article (PubMed ID: 18154203)
1. Cancer vaccines: a new frontier in prevention and treatment.
Giarelli E
Oncology (Williston Park); 2007 Oct; 21(11 Suppl Nurse Ed):11-7; discussion 18. PubMed ID: 18154203
[TBL] [Abstract][Full Text] [Related]
2. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
3. Outlining novel cellular adjuvant products for therapeutic vaccines against cancer.
Tefit JN; Serra V
Expert Rev Vaccines; 2011 Aug; 10(8):1207-20. PubMed ID: 21854313
[TBL] [Abstract][Full Text] [Related]
4. Vaccines: an innovative approach to treating cancer.
Pazdur MP; Jones JL
J Infus Nurs; 2007; 30(3):173-8. PubMed ID: 17505219
[TBL] [Abstract][Full Text] [Related]
5. Autologous versus allogeneic cell-based vaccines?
Parmiani G; Pilla L; Maccalli C; Russo V
Cancer J; 2011; 17(5):331-6. PubMed ID: 21952283
[TBL] [Abstract][Full Text] [Related]
6. Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines.
Wiedermann U; Davis AB; Zielinski CC
Breast Cancer Res Treat; 2013 Feb; 138(1):1-12. PubMed ID: 23340862
[TBL] [Abstract][Full Text] [Related]
7. Cancer vaccines: challenges and outlook in the field.
Paul S; Acres B; Limacher JM; Bonnefoy JY
IDrugs; 2007 May; 10(5):324-8. PubMed ID: 17487784
[TBL] [Abstract][Full Text] [Related]
8. Type I interferons as vaccine adjuvants against infectious diseases and cancer.
Bracci L; La Sorsa V; Belardelli F; Proietti E
Expert Rev Vaccines; 2008 Apr; 7(3):373-81. PubMed ID: 18393607
[TBL] [Abstract][Full Text] [Related]
9. Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need.
Herberman RB; Pearce HL; Lippman SM; Pyenson BS; Alberts DS
Cancer Res; 2006 Dec; 66(24):11540-9. PubMed ID: 17158189
[TBL] [Abstract][Full Text] [Related]
10. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
Koprowski H
Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
[TBL] [Abstract][Full Text] [Related]
11. Antitumor vaccination: where we stand.
Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S
Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
[TBL] [Abstract][Full Text] [Related]
12. Prevention of cancer through immunization: Prospects and challenges for the 21st century.
Frazer IH; Lowy DR; Schiller JT
Eur J Immunol; 2007 Nov; 37 Suppl 1():S148-55. PubMed ID: 17972339
[TBL] [Abstract][Full Text] [Related]
13. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
Khaliq SA; Shyum Naqvi SB; Fatima A
Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
[TBL] [Abstract][Full Text] [Related]
14. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
Mahdavi A; Monk BJ
Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
[TBL] [Abstract][Full Text] [Related]
15. Preventative and therapeutic vaccines for cervical cancer.
Roden R; Wu TC
Expert Rev Vaccines; 2003 Aug; 2(4):495-516. PubMed ID: 14711335
[TBL] [Abstract][Full Text] [Related]
16. Cytokine adjuvants for vaccine therapy of neoplastic and infectious disease.
Decker WK; Safdar A
Cytokine Growth Factor Rev; 2011 Aug; 22(4):177-87. PubMed ID: 21862380
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of papillomavirus-related cancers through immunization.
Frazer IH; Leggatt GR; Mattarollo SR
Annu Rev Immunol; 2011; 29():111-38. PubMed ID: 21166538
[TBL] [Abstract][Full Text] [Related]
18. Clinical development of MVA-based therapeutic cancer vaccines.
Acres B; Bonnefoy JY
Expert Rev Vaccines; 2008 Sep; 7(7):889-93. PubMed ID: 18767940
[TBL] [Abstract][Full Text] [Related]
19. Vaccines for immunotherapy of breast cancer and prostate cancer: new developments and comparative aspects.
Minev BR; Guo F; Gueorguieva I; Kaiser HE
In Vivo; 2002; 16(6):405-15. PubMed ID: 12494883
[TBL] [Abstract][Full Text] [Related]
20. Melanoma vaccines.
Yang JC
Cancer J; 2011; 17(5):277-82. PubMed ID: 21952276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
